Hamlet BioPharma AB publ (XSAT:HAMLET B) EV-to-Revenue : (As of Jul. 04, 2025)

Hamlet BioPharma AB publ EV-to-Revenue Chart

Hamlet BioPharma AB publ Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
EV-to-Revenue		Get a 7-Day Free Trial					-	-	-	-	-

Hamlet BioPharma AB publ Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Hamlet BioPharma AB publ's EV-to-Revenue

For the Biotechnology subindustry, Hamlet BioPharma AB publ's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamlet BioPharma AB publ's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's EV-to-Revenue falls into.

Hamlet BioPharma AB publ EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hamlet BioPharma AB publ's EV-to-Revenue for today is calculated as:

Hamlet BioPharma AB publ's current Enterprise Value is kr689.83 Mil.
Hamlet BioPharma AB publ's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ  (XSAT:HAMLET B) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hamlet BioPharma AB publ's PS Ratiofor today is calculated as:

Hamlet BioPharma AB publ's share price for today is kr3.995.
Hamlet BioPharma AB publ's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description